Author

Blake R. Wilde

University of California, Los AngelesORCID 0000-0002-8372-3954Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Assay:metabolomics· 1

Frequent Co-Authors

David B. ShackelfordiD· 2 shared Heather R. ChristofkiD· 2 shared Andrea Gallardo· 1 shared Andrew S. GoldsteiniD· 1 shared Angel RuiziD· 1 shared Brian E. KaderaiD· 1 shared Chad M. Smith· 1 shared Chris Frias· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David B. ShackelfordORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyScience AdvancesPeer-reviewedJul 31, 2026

PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma

Blake R. Wilde, Kyle D. Klingbeil, Francesca Day…·Heather R. Christofk

This study identifies PPARG as a key regulator of adipogenic differentiation in liposarcoma, showing its loss contributes to the aggressive phenotype of dedifferentiated liposarcoma.

1 citation

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 28, 2025

OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer

Matthew J. Bernard, Angel Ruiz, Johnny A. Diaz…·Andrew S. Goldstein

This study identifies OGDHL as a regulator of tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer, with implications for treatment resistance.

DOI 10.1101/2025.05.28.656673

humanproteomics

𝕏 PostBluesky